Abstract
The population pyramid is changing due to the increasing longevity of the population, making it a priority to have better knowledge of those diseases that have an increasingly major impact in advanced age. Sleep apnoea-hypopnea syndrome (SAHS) affects 15-20% of individuals over 65 years. Despite this high prevalence and the fact that one in four Spanish sleep studies are conducted on the elderly and that more 60% of these were treated with CPAP, there are few specific studies in this age group on the diagnosis and management of this syndrome. Over time, physiological increase in the number of sleep respiratory disorders may be the biggest obstacle when defining, diagnosing and treating SAHS in the elderly. In any case and while more solid scientific evidence is obtained, the Spanish SAHS Consensus, as well as the Guidelines on the diagnosis and treatment of SAHS, recommend that, within logical limits, age should not be an obstacle to offering the elderly diagnostic help and treatment similar to that offered to the rest of the population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
